PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880601
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880601
Poultry Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of poultry vaccines Market
The global poultry vaccines market is witnessing significant growth, driven by increasing demand for poultry products, rising incidence of infectious diseases, and greater awareness of flock health management. The market size was valued at USD 1.27 billion in 2024, is projected to reach USD 1.32 billion in 2025, and is expected to grow to USD 2.01 billion by 2032, representing a steady CAGR of 6.13% during the forecast period. North America dominated the market with a 45.66% share in 2024, owing to stringent regulations, advanced veterinary infrastructure, and the presence of major industry players.
The growing consumption of poultry eggs and meat worldwide is the primary driver for market expansion. According to the U.S. Department of Agriculture, 21.34 million metric tons of chicken meat were produced in 2024/2025 in the U.S., accounting for approximately 21.0% of global production. Such high production rates necessitate maintaining disease-free flocks to ensure food security, consistent supply, and high-quality protein. Vaccination serves as a critical tool to prevent outbreaks of diseases such as avian influenza, Newcastle disease, Marek's disease, and infectious bronchitis, thereby protecting economic interests and poultry productivity. In November 2024, Vaxxinova received marketing authorization from the European Commission for Vaxxon ND Clone, a vaccine targeting Newcastle Disease virus, exemplifying the active push for effective immunization.
Market Drivers and Restraints
The market is strongly supported by rising poultry consumption and increasing awareness of biosecurity practices among farmers. Vaccinations not only reduce economic losses but also enhance the overall health and productivity of poultry farms. Additionally, key players such as Zoetis Services LLC, Merck & Co., Inc., and Boehringer Ingelheim International GmbH are investing heavily in research and development to produce more effective and affordable vaccines. These strategic initiatives further reinforce market expansion.
However, the global poultry vaccines market faces challenges. Vaccine failures and "leaky" vaccine risks pose a restraint to growth. High mutation rates in poultry pathogens, such as Marek's disease and avian influenza, can reduce vaccine efficacy, leading to mortality rates ranging between 10.0% and 40.0% in vaccinated flocks, as reported in India. Such occurrences increase farmer skepticism and limit vaccine adoption.
Market Opportunities and Trends
Government-led vaccination campaigns present lucrative opportunities. For instance, in April 2025, India's Department of Animal Husbandry & Dairying (DAHD) collaborated with the poultry industry to administer vaccines against Highly Pathogenic Avian Influenza (HPAI), highlighting proactive measures to ensure food security. Such initiatives help bridge immunity gaps, particularly among small-scale farmers, and support the expansion of the poultry vaccines market.
A prominent industry trend is the shift toward in-ovo vaccination technology, which allows vaccines to be administered directly into eggs at day 18 of incubation. This approach provides chicks with early immunity, reduces labor, and eliminates stress associated with traditional subcutaneous or ocular methods. Key players are increasingly launching vaccines designed for in-ovo application. For example, HIPRA introduced EVANOVO in Europe in October 2022, a vaccine targeting coccidiosis for in-ovo administration.
Segmentation Analysis
By Technology
The inactivated vaccines segment dominated the market in 2024, driven by rising disease outbreaks and growing demand for poultry food security. Key launches, such as Zoetis Services LLC's Avian Influenza Vaccine, H5N2 subtype, in February 2025, continue to bolster the segment.
By Disease Type
The viral diseases segment accounted for the largest share in 2024, reflecting increasing threats from avian influenza, Newcastle disease, and Marek's disease. Major industry players are focusing on viral vaccines to ensure flock biosecurity.
By Route of Administration
The parenteral segment remained dominant in 2024 due to precise dose delivery and stronger immune responses. Merck & Co., Inc., received European marketing authorization in March 2024 for NOBILIS MULTRIVA REOm, an intramuscular vaccine for chickens.
By Distribution Channel
Veterinary hospitals held the leading market share in 2024, supported by active government initiatives and widespread veterinary outreach. For instance, South Africa launched a mass vaccination campaign in June 2025 targeting HPAI.
Regional Outlook
North America
The largest regional market in 2024 with USD 0.58 billion, driven by regulatory compliance, strong poultry production, and research funding. The USDA allocated USD 100 million in April 2025 for avian influenza vaccine research.
Europe & Asia Pacific
Europe is expected to reach USD 0.36 billion in 2025, supported by increasing poultry product demand and flock health initiatives. Asia Pacific is projected to attain USD 0.17 billion in 2025, ranking third globally due to expanding poultry production and rising health awareness.
Latin America & Middle East/Africa
Latin America and Middle East/Africa are expected to grow moderately, reaching USD 0.11 billion and USD 0.06 billion, respectively, in 2025, supported by government campaigns and healthcare initiatives.
Competitive Landscape
The market is semi-fragmented, with Zoetis, Merck & Co., Boehringer Ingelheim, Elanco, Ceva, HIPRA, and others actively pursuing strategic collaborations, new product launches, and geographic expansion. Notable developments include Bioveta's launch of an inactivated bacterial vaccine in July 2025 and Virbac's acquisition of Globion in India in October 2023.
With projected growth to USD 2.01 billion by 2032, the global poultry vaccines market is poised for expansion, driven by rising protein demand, technological innovations, government support, and increasing focus on flock health and biosecurity.
Segmentation By Technology
- Inactivated
- Live Attenuated
- Recombinant
- Others
By Disease Type
- Viral Diseases
- Avian Influenza
- Newcastle Disease
- Marek's Disease
- Others
- Bacterial Diseases
- Salmonellosis
- Mycoplasmosis
- Others
- Parasitic Diseases
By Route of Administration
- Parenteral
- Intranasal
- Others
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
By Region
- North America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country)
- U.S.
- Canada
- Europe (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 3.5. Market Challenges
4. Key Insights
- 4.1. Overview of Poultry Diseases by Key Countries, By Key Countries/ Region, 2024
- 4.2. Regulatory Scenario by Key Countries/ Region, 2024
- 4.3. Overview of Vaccination for Poultry Diseases
- 4.4. New Technology Launches, By Key Players
- 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Global Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast - By Technology
- 5.1.1. Inactivated
- 5.1.2. Live Attenuated
- 5.1.3. Recombinant
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Disease Type
- 5.2.1. Viral Diseases
- 5.2.1.1. Avian Influenza
- 5.2.1.2. Newcastle Disease
- 5.2.1.3. Marek's Disease
- 5.2.1.4. Others
- 5.2.2. Bacterial Diseases
- 5.2.2.1. Salmonellosis
- 5.2.2.2. Mycoplasmosis
- 5.2.2.3. Others
- 5.2.3. Parasitic Diseases
- 5.2.1. Viral Diseases
- 5.3. Market Analysis, Insights and Forecast - By Route of Administration
- 5.3.1. Parenteral
- 5.3.2. Intranasal
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.4.1. Veterinary Hospitals
- 5.4.2. Veterinary Clinics
- 5.4.3. Pharmacies & Drug Stores
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast - By Technology
- 6.1.1. Inactivated
- 6.1.2. Live Attenuated
- 6.1.3. Recombinant
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Disease Type
- 6.2.1. Poultry Influenza
- 6.2.2. Lyme Disease
- 6.2.3. Rabies
- 6.2.4. Leptospirosis
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Intranasal
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1. Veterinary Hospitals
- 6.4.2. Veterinary Clinics
- 6.4.3. Pharmacies & Drug Stores
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast - By Technology
- 7.1.1. Inactivated
- 7.1.2. Live Attenuated
- 7.1.3. Recombinant
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Disease Type
- 7.2.1. Viral Diseases
- 7.2.1.1. Avian Influenza
- 7.2.1.2. Newcastle Disease
- 7.2.1.3. Marek's Disease
- 7.2.1.4. Others
- 7.2.2. Bacterial Diseases
- 7.2.2.1. Salmonellosis
- 7.2.2.2. Mycoplasmosis
- 7.2.2.3. Others
- 7.2.3. Parasitic Diseases
- 7.2.1. Viral Diseases
- 7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1. Parenteral
- 7.3.2. Intranasal
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1. Veterinary Hospitals
- 7.4.2. Veterinary Clinics
- 7.4.3. Pharmacies & Drug Stores
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.5.1. Germany
- 7.5.2. U.K.
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast - By Technology
- 8.1.1. Inactivated
- 8.1.2. Live Attenuated
- 8.1.3. Recombinant
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Disease Type
- 8.2.1. Viral Diseases
- 8.2.1.1. Avian Influenza
- 8.2.1.2. Newcastle Disease
- 8.2.1.3. Marek's Disease
- 8.2.1.4. Others
- 8.2.2. Bacterial Diseases
- 8.2.2.1. Salmonellosis
- 8.2.2.2. Mycoplasmosis
- 8.2.2.3. Others
- 8.2.3. Parasitic Diseases
- 8.2.1. Viral Diseases
- 8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1. Parenteral
- 8.3.2. Intranasal
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1. Veterinary Hospitals
- 8.4.2. Veterinary Clinics
- 8.4.3. Pharmacies & Drug Stores
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.5.1. China
- 8.5.2. Japan
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast - By Technology
- 9.1.1. Inactivated
- 9.1.2. Live Attenuated
- 9.1.3. Recombinant
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Disease Type
- 9.2.1. Viral Diseases
- 9.2.1.1. Avian Influenza
- 9.2.1.2. Newcastle Disease
- 9.2.1.3. Marek's Disease
- 9.2.1.4. Others
- 9.2.2. Bacterial Diseases
- 9.2.2.1. Salmonellosis
- 9.2.2.2. Mycoplasmosis
- 9.2.2.3. Others
- 9.2.3. Parasitic Diseases
- 9.2.1. Viral Diseases
- 9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1. Parenteral
- 9.3.2. Intranasal
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1. Veterinary Hospitals
- 9.4.2. Veterinary Clinics
- 9.4.3. Pharmacies & Drug Stores
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast - By Technology
- 10.1.1. Inactivated
- 10.1.2. Live Attenuated
- 10.1.3. Recombinant
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Disease Type
- 10.2.1. Viral Diseases
- 10.2.1.1. Avian Influenza
- 10.2.1.2. Newcastle Disease
- 10.2.1.3. Marek's Disease
- 10.2.1.4. Others
- 10.2.2. Bacterial Diseases
- 10.2.2.1. Salmonellosis
- 10.2.2.2. Mycoplasmosis
- 10.2.2.3. Others
- 10.2.3. Parasitic Diseases
- 10.2.1. Viral Diseases
- 10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1. Parenteral
- 10.3.2. Intranasal
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1. Veterinary Hospitals
- 10.4.2. Veterinary Clinics
- 10.4.3. Pharmacies & Drug Stores
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability)
- 11.2.1. Elanco
- 11.2.2. Boehringer Ingelheim International GmbH
- 11.2.3. Virbac
- 11.2.4. Merck & Co., Inc.
- 11.2.5. Zoetis Services LLC
- 11.2.6. Ceva
- 11.2.7. Bioveta, a.s.
- 11.2.8. Indian Immunologicals Ltd.
- 11.2.9. HIPRA
List of Tables
- Table 1: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 2: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 3: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
- Table 4: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
- Table 5: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 6: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 7: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
- Table 8: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 9: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 10: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
- Table 11: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
- Table 12: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 13: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 14: North America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
- Table 15: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 16: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 17: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
- Table 18: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
- Table 19: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 20: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 21: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 22: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 23: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 24: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
- Table 25: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
- Table 26: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 27: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 28: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 29: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 30: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 31: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
- Table 32: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
- Table 33: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 34: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 35: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 36: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 37: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 38: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
- Table 39: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
- Table 40: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 41: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 42: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
List of Figures
- Figure 1: Global Poultry Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
- Figure 2: Global Poultry Vaccines Market Value Share (%), by Technology, 2024 & 2032
- Figure 3: Global Poultry Vaccines Market Value Share (%), by Disease Type, 2024 & 2032
- Figure 4: Global Poultry Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
- Figure 5: Global Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
- Figure 6: Global Poultry Vaccines Market Value Share (%), by Region, 2024 & 2032
- Figure 7: North America Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 8: North America Poultry Vaccines Market Value Share (%), by Technology, 2024
- Figure 9: North America Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 10: North America Poultry Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 11: North America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 12: North America Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 13: North America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 14: North America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 15: North America Poultry Vaccines Market Value (USD billion), By Country, 2024 & 2032
- Figure 16: North America Poultry Vaccines Market Value Share (%), By Country, 2024
- Figure 17: Europe Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 18: Europe Poultry Vaccines Market Value Share (%), by Technology, 2024
- Figure 19: Europe Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 20: Europe Poultry Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 21: Europe Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 22: Europe Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 23: Europe Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 24: Europe Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 25: Europe Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 26: Europe Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 27: Asia Pacific Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 28: Asia Pacific Poultry Vaccines Market Value Share (%), by Technology, 2024
- Figure 29: Asia Pacific Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 30: Asia Pacific Poultry Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 31: Asia Pacific Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 32: Asia Pacific Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 33: Asia Pacific Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 34: Asia Pacific Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 35: Asia Pacific Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 36: Asia Pacific Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 37: Latin America Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 38: Latin America Poultry Vaccines Market Value Share (%), by Technology, 2024
- Figure 39: Latin America Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 40: Latin America Poultry Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 41: Latin America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 42: Latin America Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 43: Latin America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 44: Latin America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 45: Latin America Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 46: Latin America Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 47: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 48: Middle East & Africa Poultry Vaccines Market Value Share (%), by Technology, 2024
- Figure 49: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 50: Middle East & Africa Poultry Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 51: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 52: Middle East & Africa Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 53: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 54: Middle East & Africa Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 55: Middle East & Africa Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 56: Middle East & Africa Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 57: Global Poultry Vaccines Market Share (%), By Company, 2024
